Cargando…

C-Peptide as a Remedy for Diabetic Microangiopathy?

Detalles Bibliográficos
Autor principal:	Waldhäusl, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526030/ https://www.ncbi.nlm.nih.gov/pubmed/23258913 http://dx.doi.org/10.2337/db12-1250

Ejemplares similares

C-peptide and Retinal Microangiopathy in Diabetes
por: Chakrabarti, Subrata, et al.
Publicado: (2004)

C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question
por: Werion, Alexis, et al.
Publicado: (2021)

Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle
por: Wehrmann, Florian, et al.
Publicado: (2023)

Type 1 diabetes care: Improvement by standardization in a diabetes rehabilitation clinic. An observational report
por: Haslacher, Helmuth, et al.
Publicado: (2018)

Type 2 diabetes care: Improvement by standardization at a diabetes rehabilitation clinic. An observational report
por: Haslacher, Helmuth, et al.
Publicado: (2019)

C-peptide persistence in type 1 diabetes: ‘not drowning, but waving’?
por: Leslie, R. David, et al.
Publicado: (2019)

Enhancing remediation by focusing on affective experience
por: Colonnello, Valentina
Publicado: (2021)

Regenerative Therapies for Diabetic Microangiopathy
por: Bassi, Roberto, et al.
Publicado: (2012)

Missing data in clinical trials: Pitfalls and remedies
por: Kaushal, Sandeep
Publicado: (2014)

Cannabis-based treatments as an alternative remedy for epilepsy
por: Ahuja, Abhimanyu S.
Publicado: (2019)

Knowledge and understanding of health insurance: challenges and remedies
por: Barnes, Andrew J., et al.
Publicado: (2017)

Meaningful mapping of remediation in longitudinal and developmental assessment models
por: Heeneman, Sylvia, et al.
Publicado: (2020)

Could the Olfactory System Be a Target for Homeopathic Remedies as Nanomedicines?
por: Courtens, Florence, et al.
Publicado: (2018)

The Role of PKM2 in Diabetic Microangiopathy
por: Tu, Chao, et al.
Publicado: (2022)

RNA‐binding proteins in diabetic microangiopathy
por: Tu, Chao, et al.
Publicado: (2022)

Diabetic endothelial microangiopathy and pulmonary dysfunction
por: Zhang, Lanlan, et al.
Publicado: (2023)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?
por: Mir, Tajamul H.
Publicado: (2021)

Are herbal remedies and dietary supplements safe and effective for breast cancer patients?
por: Cassidy, Aedin
Publicado: (2003)

Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study
por: Haslacher, Helmuth, et al.
Publicado: (2019)

Allium fistulosum congee as a home remedy to ward off the corona virus at an early stage
por: Hsu, Elisabeth, et al.
Publicado: (2020)

Macroscopic Quantum Coherence in Patient-Practitioner-Remedy Entanglement: The Quantized Fluctuation Field Perspective
por: Hankey, Alex
Publicado: (2009)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Remdesivir: Remedy the world is waiting for?
por: Suranagi, Umesh Devappa, et al.
Publicado: (2020)

Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy
por: ZHANG, XIAOYAN, et al.
Publicado: (2014)

Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot Ulcer
por: Tomita, Masuomi, et al.
Publicado: (2016)

The mitochondrial‐derived peptide MOTS‐c: a player in exceptional longevity?
por: Fuku, Noriyuki, et al.
Publicado: (2015)

Maternal major depression disorder misclassification errors: Remedies for valid individual‐ and population‐level inference
por: Owora, Arthur H.
Publicado: (2022)

Haptoglobin Polymorphism in Individuals with Type 2 Diabetic Microangiopathy
por: Amiri, Ahmad Ahmadzadeh, et al.
Publicado: (2013)

Minimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa
por: Somboonwong, Juraiporn, et al.
Publicado: (2016)

Diet, Gut, and Type 1 Diabetes: Role of Wheat-Derived Peptides?
por: Knip, Mikael
Publicado: (2009)

Glucagon‐like peptide‐1 therapy for youth with type 2 diabetes
por: Cho, Young Min
Publicado: (2022)

Aldose reductase C-106T gene polymorphism in type 2 diabetics with microangiopathy in Iranian individuals
por: Rezaee, Majid Reza Sheikh, et al.
Publicado: (2015)

C3 Glomerulopathy and Thrombotic Microangiopathy: A “Hybrid” Phenotype
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2023)

Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
por: Watts, Gerald F., et al.
Publicado: (2013)

Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes
por: James, Eddie A., et al.
Publicado: (2008)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Microangiopathy in Rheumatic Diseases
por: Lambova, Sevdalina Nikolova
Publicado: (2023)

Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction
por: Sorrentino, Francesco Saverio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gv6tsucdvss61bc9nh755tfrvg